Where Will Pacific Biosciences of California Inc (PACB) Stock Go Next After It Has Gained 7.79% in a Week?

The market has been down on Pacific Biosciences of California Inc (PACB) stock recently. PACB gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Pacific Biosciences of California Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on PACB!

See Full PACB Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With PACB Stock Today?

Pacific Biosciences of California Inc (PACB) stock is trading at $7.33 as of 9:53 AM on Tuesday, Nov 14, a gain of $0.89, or 13.82% from the previous closing price of $6.44. The stock has traded between $7.01 and $7.33 so far today. Volume today is light. So far 446,348 shares have traded compared to average volume of 5,170,652 shares.

More About Pacific Biosciences of California Inc

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. Click Here to get the full Stock Report for Pacific Biosciences of California Inc stock.